ArticleACS omega2025

Development of Novel 3‑Phenylpropanamide Derivatives as BChE Inhibitors for the Treatment of Alzheimer's Disease.

Haibo Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.